MENU

GLUE Monte Rosa Therapeutics Forecast, Technical & Fundamental Analysis

Industry Biotechnology
GLUE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
GLUE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

GLUE is expected to report earnings to rise 9.30% to -46 cents per share on November 07

Monte Rosa Therapeutics GLUE Stock Earnings Reports
Q3'24
Est.
$-0.47
Q2'24
Beat
by $0.09
Q1'24
Beat
by $0.06
Q4'23
Missed
by $0.19
Q3'23
Beat
by $0.02
The last earnings report on August 08 showed earnings per share of -43 cents, beating the estimate of -52 cents. With 191.81K shares outstanding, the current market capitalization sits at 317.30M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
321 Harrison Avenue
Phone
+1 617 949-2643
Employees
133
Web
https://www.monterosatx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME23.14-0.28
-1.20%
GameStop Corp
TSLA210.60-3.51
-1.64%
Tesla
SPY552.08-11.60
-2.06%
SPDR® S&P 500® ETF Trust
AAPL222.77-6.23
-2.72%
Apple
BTC.X57431.023000-1681.457000
-2.84%
Bitcoin cryptocurrency

GLUE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, GLUE has been loosely correlated with RXRX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if GLUE jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLUE
1D Price
Change %
GLUE100%
-5.67%
RXRX - GLUE
46%
Loosely correlated
-16.62%
NRIX - GLUE
45%
Loosely correlated
-1.35%
XNCR - GLUE
44%
Loosely correlated
-3.14%
MGTX - GLUE
41%
Loosely correlated
-3.93%
BEAM - GLUE
41%
Loosely correlated
-8.55%
More